Take a fresh look at your lifestyle.

Spain’s Rovi to make ingredients for Moderna COVID-19 vaccine

Drugmaker Rovi announced on Monday to make active ingredients for Moderna’s COVID-19 vaccine, extending an existing agreement to bottle the vaccine using ingredients that are brought in from Switzerland.

Madrid-based Rovi, whose shares rose 4% on Monday towards a record high set last month have the capacity to supply the active agents for up to 100 million vaccine doses a year at its plant in Granada via a new production line. Moderna has said it will make at least 700 million doses of vaccine in 2021, including from plants in Canada, South Korea, Europe, and the United States.

Rovi said “This investment consists of the installation of a new line supporting production phases of the active substance of the mRNA vaccine,”.